Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Sep 13, 2022

SELL
$0.05 - $0.07 $120,593 - $168,830
-2,411,871 Closed
0 $0
Q4 2021

Sep 13, 2022

BUY
$0.05 - $0.06 $120,593 - $144,712
2,411,871 New
2,411,871 $133,000

Others Institutions Holding PVCT

About PROVECTUS BIOPHARMACEUTICALS, INC.


  • Ticker PVCT
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 419,496,992
  • Market Cap $54.5M
  • Description
  • Provectus Biopharmaceuticals, Inc., a clinical-stage biotechnology company, engages in developing immunotherapy medicines based on halogenated xanthenes. It develops PV-10, an investigational autolytic cancer immunotherapy for adult solid tumor cancers, such as melanoma and gastrointestinal tumors, including hepatocellular carcinoma; colorectal ...
More about PVCT
Track This Portfolio

Track Sunflower Bank, N.A. Portfolio

Follow Sunflower Bank, N.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sunflower Bank, N.A., based on Form 13F filings with the SEC.

News

Stay updated on Sunflower Bank, N.A. with notifications on news.